BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.180
-0.050 (-4.07%)
At close: Dec 30, 2025, 4:00 PM EST
1.190
+0.010 (0.85%)
After-hours: Dec 30, 2025, 5:47 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $12.52 million as of December 30, 2025. Its market cap has increased by 26.47% in one year.
Market Cap
12.52M
Enterprise Value
7.87M
1-Year Change
26.47%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $12.52M, a decrease of -56.93%. That is a compound annual growth rate of -8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 13.05M | 30.62% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |